Biotechnology News

July 28, 2014

WILMINGTON, N.C.--(BUSINESS WIRE)--Pharmaceutical Product Development, LLC (PPD) today announced the appointment of Henry Levy as executive vice president of client development and commercial services. Levy leads PPD’s customer-facing teams to...

July 28, 2014

SAN ANTONIO--(BUSINESS WIRE)--CelluTome™ Epidermal Harvesting System Makes Podiatry Today’s Top 10 New Innovation List

July 28, 2014

ZURICH--(BUSINESS WIRE)--Redbiotec, specializing in vaccine development, has successfully applied its unique expertise and innovative technology platform to complete a collaborative program with GE Healthcare Life Sciences.

July 28, 2014

NORWELL, Mass.--(BUSINESS WIRE)--Prolonged bed rest due to stroke, traumatic brain injury or spinal cord injury can cause adverse effects such as cardiovascular, respiratory and musculoskeletal deconditioning. It also increases the risk of...

July 28, 2014

PORT ST. LUCIE, Fla.--(BUSINESS WIRE)--The Vaccine & Gene Therapy Institute of Florida (VGTI Florida®), has filed a new patent application covering an invention that includes potent anti-viral compounds.

July 28, 2014

WASHINGTON--(BUSINESS WIRE)--Published today in Applied Optics, a new wearable device may detect a common diabetes complication--called diabetic autonomic neuropathy--sooner, leading to better treatment outcomes.

July 28, 2014

OXFORD, England--(BUSINESS WIRE)--CN Bio Innovations announced today that it has signed a research agreement with Imperial to advance the development of in vitro models of liver infection based on the company’s LiverChip™ platform.

July 28, 2014

LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that company management will discuss Cubist’s business activities and financial outlook at investor conferences during August 2013. On Wednesday,...

July 28, 2014

CAMBRIDGE, Mass. & BRUSSELS--(BUSINESS WIRE)--Technology company MC10 Inc. and global biopharmaceutical company UCB announced that they have entered into a partnership to develop MC10’s Biostamp™ platform for patient-focused disease...

July 28, 2014

SAN FRANCISCO & RALEIGH-DURHAM, N.C.--(BUSINESS WIRE)--Cytonet announced today that new research on its investigational liver cell therapy (LCT) was presented on July 27, 2014 at the 2014 World Transplant Congress (WTC) in San Francisco. The...

July 28, 2014

CHICAGO--(BUSINESS WIRE)--Thermo Fisher Scientific today highlighted its expanded portfolio of instruments, equipment, consumables and software for improving accuracy and efficiency in the clinical laboratory at AACC 2014.

July 28, 2014

BROOKLINE, Mass.--(BUSINESS WIRE)--The studies lay the groundwork for tests that use genomic markers as part of a surveillance program to detect and respond to early signs of graft injury. Tests will be available through a CLIA lab.

July 28, 2014

CHICAGO--(BUSINESS WIRE)--Thermo Fisher Scientific has unveiled three Class-1 Medical Devices for use as components of laboratory-developed tests for analyzing patient samples: a mass spec, liquid chromatograph and software.

July 28, 2014

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--SurModics IVD, a market leader for in vitro diagnostic assay components, is introducing StabilZyme® Protein-Free AP Stabilizer at the American Association for Clinical Chemistry meeting in Chicago.

July 28, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Epizyme, Inc. (NASDAQ:EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, announced today that it will host a conference...

July 28, 2014

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker (NASDAQ:BRKR) today announced that it has acquired Vutara Incorporated, a technology leader in high-speed, three-dimensional (3D), super-resolution fluorescence microscopy for life science applications....

July 28, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Emulate, Inc. announced the company’s launch with a $12 million Series A financing to commercialize a first-in-kind ‘Organs-on-Chips’ platform incubated at Harvard that mimics human physiology.

July 28, 2014

CORK, Ireland--(BUSINESS WIRE)--Results from the Phase 2 COSMOS (Combination Of SiMeprevir and sOfosbuvir in HCV genotype 1 infected patientS) clinical study were published July 28 in The Lancet, demonstrating that 92 percent of genotype 1...

July 28, 2014

REDWOOD CITY, Calif.--(BUSINESS WIRE)--PaxVax, Inc., a specialty vaccine company focused on travel and biodefense, today announced it has closed up to $50 million in financing from Pharmakon Advisors and a $12 million Series B extension.

July 28, 2014

NEW YORK--(BUSINESS WIRE)--Retrophin, Inc. (NASDAQ:RTRX) today announced that on July 17, 2014 it submitted a proposal to the Board of Directors of Clinuvel Pharmaceuticals Ltd (ASX:CUV) to acquire by scheme of arrangement all of the shares of...

July 28, 2014

SAN DIEGO--(BUSINESS WIRE)--Batu Biologics announced today that it’s President and CEO, Samuel C. Wagner, was featured in the weekly business publication, the San Diego Business Journal. The article, which was published in the July 21st edition,...

July 26, 2014

SAN DIEGO--(BUSINESS WIRE)--PROSENSA HOLDING N.V. SHAREHOLDER ALERT: Johnson & Weaver, LLP Reminds Investors of Upcoming September 16, 2014 Deadline; Encourages Investors with Significant Losses to Contact the Firm

July 25, 2014

WASHINGTON--(BUSINESS WIRE)--Marker Test Diagnostics, an international supplier to the drug testing industry, announced today that representatives from the company will attend the 2014 AACC Conference.

July 25, 2014

CHICAGO--(BUSINESS WIRE)--BIT Group will showcase its newest in-vitro diagnostic instrumentation technology for IVD OEM’s at the 2014 AACC Annual Conference held in Chicago, IL on July 27- July 31.

July 25, 2014

MORRISTOWN, N.J.--(BUSINESS WIRE)--Pernix Therapeutics Holdings, Inc. (NASDAQ: PTX), a specialty pharmaceutical company, today announced that it will release its second quarter 2014 financial results before the U.S. stock market opens on Monday,...

July 25, 2014

WATERTOWN, Mass.--(BUSINESS WIRE)--Dicerna will announce Q2 2014 earnings and corporate update on Thursday, August 7, 2014 after market closes and will host a conference call at 4:30 pm ET that day.

July 25, 2014

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus announced today that its Board of Directors has approved a $0.05 per share cash dividend to be distributed on August 11, 2014, for shareholders of record as of August 4, 2014.

July 25, 2014

PARIS--(BUSINESS WIRE)--THERAVECTYS announced that it filed a lawsuit against Seattle-based Immune Design Corp. (“IDC”) in the Delaware Court of Chancery and is seeking preliminary and permanent injunctive relief, as well as monetary damages. In...

July 25, 2014

PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound care, announces that Edward J. Quilty, its chief executive officer, delivered a presentation highlighting MEDIHONEY® and...

July 25, 2014

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (NASDAQ:GILD) today announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA), has adopted a positive...

July 25, 2014

BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix initiates Initial Public Offering

July 24, 2014

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus provides additional details regarding yesterday's announced acquisition of Cognigen Corp. An investor conference call to discuss it is scheduled for Friday, July 25, at 1:15 pm PDT.

July 24, 2014

WALTHAM, Mass.--(BUSINESS WIRE)--The Board of Directors of PerkinElmer, Inc. (NYSE: PKI), declared a regular quarterly dividend of $0.07 per share of common stock on July 24, 2014. This dividend is payable on November 7, 2014, to all shareholders...

July 24, 2014

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences today announced that James E. Doyle and Maneesh K. Arora were elected to company’s board of directors at its annual meeting. Lionel N. Sterling was reelected to the board.

July 24, 2014

DUBLIN--(BUSINESS WIRE)--Alkermes plc (NASDAQ: ALKS) will host a conference call at 8:30 a.m. EDT (1:30 p.m. BST) on Thursday, July 31, 2014, to discuss the company’s financial results for the second quarter of 2014. Management will review the...

July 24, 2014

EDMONTON, Alberta--(BUSINESS WIRE)--NanoSpeed is pleased to announce that they have appointed an exclusive European distributor for their 25-OH Vitamin D deficiency test kit - Test4D™ following the announcement last week that Test4D™ is CE marked...

July 24, 2014

PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--STENTYS First Half 2014 Revenues Rise 18%

July 24, 2014

PARIS & COPENHAGEN, Denmark--(BUSINESS WIRE)--Regulatory News: In continuation of their joint company announcement of July 23, 2014, BioAlliance Pharma SA (Paris:BIO) (Euronext Paris – BIO), an innovative company specialized in the...

July 24, 2014

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE:A) today announced it has extended a co-marketing agreement with MRM Proteomics Inc., a leading provider of advanced protein quantitation, biomarker and proteomic services. The...

July 24, 2014

NEWTON, Mass.--(BUSINESS WIRE)--Unique combination of science, technology and healthcare found in Massachusetts enables the company to collaborate with innovative biotechs and healthcare organizations

July 24, 2014

SEATTLE--(BUSINESS WIRE)--TapImmune Inc. (OTCQB:TPIV), announces successful outcome of proceedings against Michael Gardner after almost 2 years of litigation. The International Center for Dispute Resolution International Arbitration Tribunal has...

July 24, 2014

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories announces its Investor Day on August 12, 2014 at 8:30 a.m. EDT in New York or via webcast at ir.criver.com

July 24, 2014

BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases, today announced that published results...

July 24, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--BIND’s management team will host a conference call/audio webcast at 8:30 a.m. ET on Thursday, August 7, 2014 to discuss 2nd quarter 2014 financial results and recent business developments.

July 24, 2014

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck today announced that the first patient has been enrolled in a global Phase 3 clinical study of letermovir (MK-8228), an investigational antiviral agent.

July 24, 2014

CINCINNATI--(BUSINESS WIRE)--Meridian Bioscience, Inc. (NASDAQ: VIVO) today: reported fiscal 2014 third quarter and first nine months net sales of $47.2 million and $142.1 million, respectively, flat and an increase of 2%, respectively, from the...